Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
17.79
-0.35 (-1.93%)
At close: Oct 14, 2025, 4:00 PM EDT
18.00
+0.21 (1.18%)
After-hours: Oct 14, 2025, 7:18 PM EDT

Mesoblast Revenue

In the fiscal year ending June 30, 2025, Mesoblast had annual revenue of $17.20M with 191.39% growth. Mesoblast had revenue of $14.04M in the half year ending June 30, 2025, with 244.25% growth.

Revenue (ttm)
$17.20M
Revenue Growth
+191.39%
P/S Ratio
133.15
Revenue / Employee
$212,321
Employees
81
Market Cap
2.29B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202517.20M11.30M191.39%
Jun 30, 20245.90M-1.60M-21.32%
Jun 30, 20237.50M-2.71M-26.54%
Jun 30, 202210.21M2.78M37.36%
Jun 30, 20217.43M-24.72M-76.88%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings